Titelia

Funds holding Passage Bio Inc

ISIN US7027122099 · United States

Fund holders
9
Of which ETFs
1 8 other funds
Value held
754.6K $
Share of capital
4.6 % of 3.2M shares on Feb 26, 2026
FundSharesValueWeight in fundShare of capital
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS 78,764384.4K $2.46 %as of Jun 30, 2026 ↗
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 35,200171.8K $0.00 %1.10 %as of Jun 30, 2026 ↗
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 18,535106.9K $0.00 %0.58 %as of May 31, 2026 ↗
Fidelity Total Market Index Fund Fidelity Concord Street Trust 6,42737.1K $0.20 %as of May 31, 2026 ↗
Fidelity Series Total Market Index Fund Fidelity Concord Street Trust 4,78327.6K $0.15 %as of May 31, 2026 ↗
LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST 2,0229.9K $0.00 %0.06 %as of Jun 30, 2026 ↗
Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust 1,89710.9K $0.06 %as of May 31, 2026 ↗
Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust 7923.5K $0.02 %as of Jul 31, 2026 ↗
Diversified Equity Alpha Master Portfolio Master Investment Portfolio 5042.5K $0.00 %0.02 %as of Jun 30, 2026 ↗

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

FundWeight in fund
LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST 0.00 %as of Jun 30, 2026 ↗
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 0.00 %as of May 31, 2026 ↗
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 0.00 %as of Jun 30, 2026 ↗
Diversified Equity Alpha Master Portfolio Master Investment Portfolio 0.00 %as of Jun 30, 2026 ↗

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterHoldersChangeSharesChange
2026Q39-4148,924+5.4 %
2026Q213+2141,317+2.3 %
2026Q111+3138,169-3.2 %
2025Q48142,720

Institutional managers

30 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.

ManagerSharesValue
Lynx1 Capital Management LP623,7044.9M $as of Mar 31, 2026
Vestal Point Capital, LP305,0002.4M $as of Mar 31, 2026
RENAISSANCE TECHNOLOGIES LLC133,6121M $as of Mar 31, 2026
Eversept Partners, LP131,5811M $as of Mar 31, 2026
Yiheng Capital Management, L.P.86,097675.9K $as of Mar 31, 2026
Erste Asset Management GmbH85,262526.9K $as of Mar 31, 2026
Ikarian Capital, LLC68,124534.8K $as of Mar 31, 2026
GEODE CAPITAL MANAGEMENT, LLC41,380324.9K $as of Mar 31, 2026
BlackRock, Inc.28,595224.5K $as of Mar 31, 2026
UBS Group AG27,501215.9K $as of Mar 31, 2026
ACADIAN ASSET MANAGEMENT LLC24,196189 $as of Mar 31, 2026
Verdad Advisers, LP22,128173.7K $as of Mar 31, 2026
DIADEMA PARTNERS LP19,530153.3K $as of Mar 31, 2026
BOOTHBAY FUND MANAGEMENT, LLC18,871148.1K $as of Mar 31, 2026
XTX Topco Ltd12,62799.1K $as of Mar 31, 2026
Fiduciary Trust Co10,75084.4K $as of Mar 31, 2026
Persistent Asset Partners Ltd4,95538.9K $as of Mar 31, 2026
MORGAN STANLEY2,65020.8K $as of Mar 31, 2026
Rockefeller Capital Management L.P.8006.3K $as of Mar 31, 2026
Tower Research Capital LLC (TRC)5023.9K $as of Mar 31, 2026
BARCLAYS PLC2121.7K $as of Mar 31, 2026
SBI Securities Co., Ltd.124973 $as of Mar 31, 2026
WELLS FARGO & COMPANY/MN115903 $as of Mar 31, 2026
Parallel Advisors, LLC16126 $as of Mar 31, 2026
OSAIC HOLDINGS, INC.15117 $as of Mar 31, 2026

Declared shareholders of Passage Bio Inc

There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.

ShareholderDeclared stakeShares
Vestal Point Capital, LP and 1 other0.00 %0as of Jun 30, 2026 · SCHEDULE 13G
Cite this page

Titelia. "Funds holding Passage Bio Inc". https://titelia.com/en/stocks/passage-bio-inc-US7027122099